Endocrinology

The Type 1 Diabetes Grand Challenge

The Novel insulins Innovation Incubator call from the Type 1 Diabetes Grand Challenge is designed to support transformative research in the field of insulin development. This funding call is open to academic groups and small to medium size biotechnology and pharmaceutical companies without geographical restrictions.
Award programme/theme
Project grant
Funding amount range
£250,001 to £500,000
Maximum duration
1 year
Submission deadline

JDRF - Glycaemic and beta cell monitoring in individuals at risk of type 1 diabetes

The aim of this call is advancing our understanding of glycaemic changes during disease progression in presymptomatic individuals (Stages 1 and 2), with the potential to improve progression biomarkers and monitoring their transition to clinical diagnosis (Stage 3). The focus of this call is the improvement of current or new metabolic risk assessment tools and their integration into clinically and commercially utilized testing platforms.
Award programme/theme
Project grant
Funding amount range
Over £500,000
Maximum duration
3 years
Submission deadline

JDRF – Innovative Awards

JDRF provides seed funding for highly innovative, high risk high reward research with significant potential to accelerate the mission of JDRF. Proposals should address key outstanding questions and have the potential to lead to a challenge or a change in the current paradigm or conventional wisdom and/or lead to a ground breaking discovery.
Award programme/theme
Project grant
Funding amount range
£100,001 to £250,000
Maximum duration
1 year
Submission deadline

JDRF - Development of Interventions to Modulate Immune Cell Trafficking in T1D

The goal of this funding opportunity is to accelerate the identification and validation of reagents that promote immune rebalance and the protection of beta cell function through modulating the trafficking of immune cells to the pancreatic islets. Proposals submitted for this opportunity should describe the preclinical or clinical development of therapeutic strategies targeting the trafficking of disease-relevant immune cell populations.
Award programme/theme
Project grant
Funding amount range
Over £500,000
Maximum duration
3 years
Submission deadline